5-37183664-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001384732.1(CPLANE1):​c.4517A>G​(p.His1506Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000979 in 1,605,066 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00088 ( 0 hom., cov: 32)
Exomes š‘“: 0.00099 ( 3 hom. )

Consequence

CPLANE1
NM_001384732.1 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:6

Conservation

PhyloP100: -0.840

Publications

3 publications found
Variant links:
Genes affected
CPLANE1 (HGNC:25801): (ciliogenesis and planar polarity effector complex subunit 1) The protein encoded by this gene has putative coiled-coil domains and may be a transmembrane protein. Defects in this gene are a cause of Joubert syndrome (JBTS). [provided by RefSeq, May 2012]
CPLANE1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 17
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006870568).
BP6
Variant 5-37183664-T-C is Benign according to our data. Variant chr5-37183664-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210553.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00088 (134/152350) while in subpopulation NFE AF = 0.0015 (102/68026). AF 95% confidence interval is 0.00126. There are 0 homozygotes in GnomAd4. There are 58 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPLANE1NM_001384732.1 linkc.4517A>G p.His1506Arg missense_variant Exon 26 of 53 ENST00000651892.2 NP_001371661.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPLANE1ENST00000651892.2 linkc.4517A>G p.His1506Arg missense_variant Exon 26 of 53 NM_001384732.1 ENSP00000498265.2 A0A494BZW6

Frequencies

GnomAD3 genomes
AF:
0.000880
AC:
134
AN:
152232
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00150
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000892
AC:
212
AN:
237794
AF XY:
0.000931
show subpopulations
Gnomad AFR exome
AF:
0.000198
Gnomad AMR exome
AF:
0.000123
Gnomad ASJ exome
AF:
0.000212
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000141
Gnomad NFE exome
AF:
0.00164
Gnomad OTH exome
AF:
0.00137
GnomAD4 exome
AF:
0.000989
AC:
1437
AN:
1452716
Hom.:
3
Cov.:
31
AF XY:
0.00101
AC XY:
729
AN XY:
722226
show subpopulations
African (AFR)
AF:
0.000213
AC:
7
AN:
32920
American (AMR)
AF:
0.000139
AC:
6
AN:
43154
Ashkenazi Jewish (ASJ)
AF:
0.000349
AC:
9
AN:
25776
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39564
South Asian (SAS)
AF:
0.000571
AC:
48
AN:
84010
European-Finnish (FIN)
AF:
0.000533
AC:
28
AN:
52550
Middle Eastern (MID)
AF:
0.000543
AC:
3
AN:
5524
European-Non Finnish (NFE)
AF:
0.00117
AC:
1300
AN:
1109246
Other (OTH)
AF:
0.000600
AC:
36
AN:
59972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
64
128
193
257
321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000880
AC:
134
AN:
152350
Hom.:
0
Cov.:
32
AF XY:
0.000779
AC XY:
58
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41580
American (AMR)
AF:
0.000261
AC:
4
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00150
AC:
102
AN:
68026
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.000759
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00129
AC:
11
ExAC
AF:
0.00104
AC:
126
Asia WGS
AF:
0.000289
AC:
1
AN:
3470

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 02, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 07, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1Benign:2
May 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome 17 Uncertain:1Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Mar 16, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Benign:1
Apr 17, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.47
DANN
Benign
0.44
DEOGEN2
Benign
0.0040
T;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0017
N
LIST_S2
Benign
0.10
.;T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.0069
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.84
PROVEAN
Benign
-0.090
N;N;N
REVEL
Benign
0.037
Sift
Benign
0.16
T;T;T
Sift4G
Benign
0.088
T;T;T
Vest4
0.094
MVP
0.17
MPC
0.15
ClinPred
0.0019
T
GERP RS
-0.54
Varity_R
0.037
gMVP
0.050
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141911199; hg19: chr5-37183766; API